Search research articles
Contact Us
Filters
Showing results (11-20 of 98) with videos related to
Page
of 10
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver
|
June 3, 2022
T-cell driven allergic cutaneous reaction complicating treatment of hepatitis delta virus infection with bulevirtide
Patrick Behrendt, Stephan Traidl, Klaus Hans Wolfgang Böker, et al.
European Journal of Gastroenterology & Hepatology
|
September 18, 2007
Sustained HCV-RNA response and hepatitis Bs seroconversion after individualized antiviral therapy with pegylated interferon alpha plus ribavirin and active vaccination in a hepatitis C virus/hepatitis B virus-coinfected patient
Andrej Potthoff, Katja Deterding, Christian Trautwein, et al.
Medicine
|
July 14, 2021
Poor clinical and virological outcome of nucleos(t)ide analogue monotherapy in HBV/HDV co-infected patients
Laura Scheller, Gudrun Hilgard, Olympia Anastasiou, et al.
Journal of Viral Hepatitis
|
January 17, 2023
Kinetics and predictive value of HBcrAg, HBV RNA and anti-HBc during bulevirtide treatment of chronic HDV-infected patients
Lisa Sandmann, Katja Deterding, Birgit Bremer, et al.
European Journal of Gastroenterology & Hepatology
|
April 14, 2020
Liver stiffness across different chronic liver disease under therapy with statin in a real life cohort
Antoaneta A Markova, Katja Deterding, Kerstin Port, et al.
Journal of Hepatology
|
November 28, 2017
Stomach reduction or gastric bypass as risk factor for treatment failure after DAA therapy for hepatitis C?
Katharina L Hupa, Katja Deterding, Kerstin Port, et al.
The Journal of Infectious Diseases
|
September 30, 2016
Direct-Acting Antiviral-Induced Hepatitis C Virus Clearance Does Not Completely Restore the Altered Cytokine and Chemokine Milieu in Patients With Chronic Hepatitis C
Julia Hengst, Christine Susanne Falk, Verena Schlaphoff, et al.
Zeitschrift Fur Gastroenterologie
|
December 11, 2023
Antiviral Therapy of Chronic Hepatitis D Virus Infection - Addendum to the S3 Guideline "Prophylaxis, Diagnosis and Therapy of Hepatitis B Virus Infection" of the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS)
Lisa Sandmann, Thomas Berg, Katja Deterding, et al.
Zeitschrift Fur Gastroenterologie
|
December 11, 2023
Lisa Sandmann, Thomas Berg, Katja Deterding, et al.
Journal of Viral Hepatitis
|
March 16, 2023
Bile acid increase during bulevirtide treatment of hepatitis D is not associated with a decline in HDV RNA
Katja Deterding, Chengjian Xu, Kerstin Port, et al.
Page
of 10
Search research articles
Search
Showing results (11-20 of 98) with videos related to
Sort By:
Page
of 10
Liver International : Official Journal of the International Association for the Study of the Liver
|
June 3, 2022
T-cell driven allergic cutaneous reaction complicating treatment of hepatitis delta virus infection with bulevirtide
Patrick Behrendt, Stephan Traidl, Klaus Hans Wolfgang Böker, et al.
European Journal of Gastroenterology & Hepatology
|
September 18, 2007
Sustained HCV-RNA response and hepatitis Bs seroconversion after individualized antiviral therapy with pegylated interferon alpha plus ribavirin and active vaccination in a hepatitis C virus/hepatitis B virus-coinfected patient
Andrej Potthoff, Katja Deterding, Christian Trautwein, et al.
Medicine
|
July 14, 2021
Poor clinical and virological outcome of nucleos(t)ide analogue monotherapy in HBV/HDV co-infected patients
Laura Scheller, Gudrun Hilgard, Olympia Anastasiou, et al.
Journal of Viral Hepatitis
|
January 17, 2023
Kinetics and predictive value of HBcrAg, HBV RNA and anti-HBc during bulevirtide treatment of chronic HDV-infected patients
Lisa Sandmann, Katja Deterding, Birgit Bremer, et al.
European Journal of Gastroenterology & Hepatology
|
April 14, 2020
Liver stiffness across different chronic liver disease under therapy with statin in a real life cohort
Antoaneta A Markova, Katja Deterding, Kerstin Port, et al.
Journal of Hepatology
|
November 28, 2017
Stomach reduction or gastric bypass as risk factor for treatment failure after DAA therapy for hepatitis C?
Katharina L Hupa, Katja Deterding, Kerstin Port, et al.
The Journal of Infectious Diseases
|
September 30, 2016
Direct-Acting Antiviral-Induced Hepatitis C Virus Clearance Does Not Completely Restore the Altered Cytokine and Chemokine Milieu in Patients With Chronic Hepatitis C
Julia Hengst, Christine Susanne Falk, Verena Schlaphoff, et al.
Zeitschrift Fur Gastroenterologie
|
December 11, 2023
Antiviral Therapy of Chronic Hepatitis D Virus Infection - Addendum to the S3 Guideline "Prophylaxis, Diagnosis and Therapy of Hepatitis B Virus Infection" of the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS)
Lisa Sandmann, Thomas Berg, Katja Deterding, et al.
Zeitschrift Fur Gastroenterologie
|
December 11, 2023
Lisa Sandmann, Thomas Berg, Katja Deterding, et al.
Journal of Viral Hepatitis
|
March 16, 2023
Bile acid increase during bulevirtide treatment of hepatitis D is not associated with a decline in HDV RNA
Katja Deterding, Chengjian Xu, Kerstin Port, et al.
Page
of 10